Savoldo B, Sammarelli G, Dotti G, Garau D, Regazzi E, Cilloni D, Tabilio A, Rizzoli V, Carlo-Stella C
Department of Hematology, Bone Marrow Transplantation Unit, University of Parma, Italy.
Leukemia. 1998 Mar;12(3):434-40. doi: 10.1038/sj.leu.2400942.
Single-colony karyotyping (SCK) and reverse-transcription polymerase chain reaction (RT-PCR) are two increasingly used techniques for the quantification of leukemic colonies generated by chronic myelogenous leukemia (CML) cell fractions purged or selected in vitro. Recently, the existence of Philadelphia (Ph) chromosome positive progenitors with a silent BCR-ABL gene has been reported, thus raising concerns on the use of RT-PCR for detecting BCR-ABL positive progenitors. In order to investigate this issue further, colonies (n = 204) generated by mononuclear (MNC) or CD34+ CML cells were individually harvested, divided into two aliquots and analyzed both at the cytogenetic level to detect the Ph chromosome, and the molecular level to detect BCR-ABL transcripts. The mean (+/- s.d.) percentages of colonies analyzable by either SCK or RT-PCR were 74 +/- 16% and 86 +/- 16%, respectively. A significant percentage of colonies (67 +/- 19%) could be successfully analyzed by both SCK and RT-PCR. Although the majority of these colonies (97 +/- 5%) were Ph-positive and BCR-ABL-positive, a negligible percentage (4%) of progenitors were Ph-positive but BCR-ABL-negative. In order to test the influence of colony size on the outcome of molecular analysis, the efficiency of our RT-PCR assay in detecting BCR-ABL transcripts was investigated by means of experiments in which the number of cells used to start RNA extraction was serially reduced. These experiments showed that at least 150 cells were necessary to achieve a reproducible amplification of BCR-ABL transcripts. By correlating the size of harvested colonies with the outcome of molecular analysis, it was evident that BCR-ABL-negative but Ph-positive colonies represented false negative results occurring when a number of leukemic cells below the detection limit of our RT-PCR assay was analyzed. In conclusion, our data demonstrate that individual CML colonies grown in semisolid culture assays can be indifferently analyzed by SCK or RT-PCR, and support an extensive use of a carefully standardized RT-PCR assay to estimate the leukemic burden within samples which have been purged and selected in vitro.
单克隆核型分析(SCK)和逆转录聚合酶链反应(RT-PCR)是两种越来越多地用于定量慢性粒细胞白血病(CML)细胞组分在体外清除或选择后产生的白血病集落的技术。最近,有报道称存在具有沉默BCR-ABL基因的费城(Ph)染色体阳性祖细胞,这引发了对使用RT-PCR检测BCR-ABL阳性祖细胞的担忧。为了进一步研究这个问题,对单核细胞(MNC)或CD34 + CML细胞产生的集落(n = 204)进行单独收获,分成两份,并在细胞遗传学水平上分析以检测Ph染色体,在分子水平上分析以检测BCR-ABL转录本。通过SCK或RT-PCR可分析的集落的平均(+/-标准差)百分比分别为74 +/- 16%和86 +/- 16%。相当比例的集落(67 +/- 19%)可以通过SCK和RT-PCR成功分析。虽然这些集落中的大多数(97 +/- 5%)是Ph阳性和BCR-ABL阳性,但可忽略不计的祖细胞百分比(4%)是Ph阳性但BCR-ABL阴性。为了测试集落大小对分子分析结果的影响,通过一系列实验研究了我们的RT-PCR检测在检测BCR-ABL转录本方面的效率,在这些实验中,用于开始RNA提取的细胞数量依次减少。这些实验表明,至少需要150个细胞才能实现BCR-ABL转录本的可重复扩增。通过将收获的集落大小与分子分析结果相关联,很明显,BCR-ABL阴性但Ph阳性的集落代表了在分析低于我们RT-PCR检测限的白血病细胞数量时出现的假阴性结果。总之,我们的数据表明,在半固体培养试验中生长的单个CML集落可以通过SCK或RT-PCR进行无差别分析,并支持广泛使用经过仔细标准化的RT-PCR检测来估计在体外清除和选择的样品中的白血病负担。